BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) shares traded down 2% on Monday . The company traded as low as $1.1686 and last traded at $1.1957. 56,672 shares were traded during mid-day trading, an increase of 36% from the average session volume of 41,636 shares. The stock had previously closed at $1.22.
BioRestorative Therapies Trading Down 2.0%
The stock has a market capitalization of $10.61 million, a P/E ratio of -0.81 and a beta of 0.28. The business has a fifty day simple moving average of $1.22 and a 200 day simple moving average of $1.44.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
